Clinical Trial Update: The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease [NA]

View source ↗

Summary

A completed trial evaluating Molecular Breast Imaging (MBI) for distinguishing benign from malignant breast disease, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Neoplasms

Snippet

Sponsor: University of Pittsburgh | Conditions: Breast Abnormalities | NA | Status: COMPLETED | Results posted: 2016-09-20